EXPONENT INC
Business
Exponent, Inc. is a science and engineering consulting firm providing interdisciplinary solutions to complex technical problems across 90+ disciplines. The company offers advisory services in failure analysis, product safety, regulatory compliance, and technology evaluation through 17 practices organized in two segments: Engineering and Other Scientific (biomechanics, civil engineering, mechanical engineering, data sciences, and others) and Environmental and Health (chemical regulation, ecological sciences, environmental remediation, and toxicology). Services are delivered globally to clients in consumer products, energy, transportation, chemical, and other industries on a project-by-project basis using time-and-material or fixed-price engagement models.
Summary from 10-K filed 2026-02-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenues before reimbursements | 537 | 518 | 497 | 464 | 435 | |
| Reimbursements | 45 | 40 | 40 | 49 | 31 | |
| Revenues | 582 | 559 | 537 | 513 | 466 | |
| Compensation and related expenses | 342 | 330 | 320 | 264 | 278 | |
| Other operating expenses | 49 | 46 | 42 | 35 | 33 | |
| Reimbursable expenses | 45 | 40 | 40 | 49 | 31 | |
| General and administrative expenses | 26 | 23 | 24 | 24 | 15 | |
| Total operating expenses | 462 | 439 | 425 | 372 | 357 | |
| Operating income | 120 | 120 | 111 | 141 | 109 | |
| Interest income | 9 | 10 | 7 | 2 | 66,000 | |
| Miscellaneous income, net | 18 | 18 | 17 | −11 | 17 | |
| Income before income taxes | 147 | 147 | 136 | 132 | 126 | |
| Provision for income taxes | 41 | 38 | 36 | 30 | 25 | |
| Net income | 106 | 109 | 100 | 102 | 101 | |
| Basic (in dollars per share) | 2.08 | 2.13 | 1.96 | 1.98 | 1.92 | |
| Diluted (in dollars per share) | 2.07 | 2.11 | 1.94 | 1.96 | 1.9 | |
| Basic (in shares) | 51 | 51 | 51 | 52 | 53 | |
| Diluted (in shares) | 51 | 52 | 52 | 52 | 53 | |
| Cash dividends declared per common share (in dollars per share) | 1.2 | 1.12 | 1.04 | 0.96 | 0.8 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 222 | 259 | 187 | 161 | 298 | |
| Accounts receivable, net of allowance for contract losses and doubtful accounts of $ 7,478 and $6,141, respectively | 182 | 161 | 167 | 170 | 140 | |
| Prepaid expenses and other current assets | 24 | 27 | 25 | 18 | 15 | |
| Total current assets | 428 | 447 | 380 | 349 | 453 | |
| Property, equipment and leasehold improvements, net | 72 | 73 | 75 | 66 | 60 | |
| Operating lease right-of-use assets | 73 | 75 | 25 | 18 | 14 | |
| Goodwill | 9 | 9 | 9 | 9 | 9 | |
| Deferred income taxes | 67 | 57 | 54 | 54 | 47 | |
| Deferred compensation plan assets | 123 | 110 | 101 | 89 | 100 | |
| Other assets | 5 | 6 | 4 | 2 | 2 | |
| Total assets | 778 | 777 | 647 | 587 | 684 | |
| Accounts payable and accrued liabilities | 31 | 22 | 22 | 29 | 25 | |
| Accrued payroll and employee benefits | 121 | 119 | 112 | 106 | 104 | |
| Deferred revenues | 19 | 16 | 22 | 19 | 20 | |
| Operating lease liabilities | 7 | 5 | 6 | 5 | 5 | |
| Total current liabilities | 178 | 163 | 162 | 159 | 153 | |
| Other liabilities | 5 | 4 | 3 | 2 | 3 | |
| Deferred compensation plan liabilities | 129 | 113 | 103 | 91 | 101 | |
| Operating lease liabilities | 76 | 76 | 22 | 13 | 10 | |
| Total liabilities | 387 | 356 | 291 | 266 | 267 | |
| Commitments and contingencies (Note 13) | — | — | — | — | — | |
| Preferred stock, $0.001 par value; 2,000 shares authorized; no shares outstanding | — | — | — | — | — | |
| Common stock, $0.001 par value; 120,000 shares authorized; 65,707 shares issued | 66,000 | 66,000 | 66,000 | 66,000 | 66,000 | |
| Additional paid-in capital | 370 | 346 | 321 | 301 | 281 | |
| Foreign currency translation adjustments | −2 | −4 | −3 | −4 | −2 | |
| Retained earnings | 668 | 624 | 574 | 529 | 478 | |
| Treasury stock, at cost: 16,087 and 14,893 shares held, respectively | −646 | −545 | −537 | −506 | −341 | |
| Total stockholders equity | 390 | 421 | 356 | 321 | 417 | |
| Total liabilities and stockholders equity | 778 | 777 | 647 | 587 | 684 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net income | 106 | 109 | 100 | 102 | 101 | |
| Depreciation and amortization of property, equipment and leasehold improvements | 10 | 10 | 9 | 7 | 6 | |
| Provision for contract losses and doubtful accounts | 3 | 4 | 3 | 3 | 2 | |
| Stock-based compensation | 24 | 23 | 20 | 20 | 19 | |
| Deferred income tax provision | −10 | −3 | 85,000 | −7 | −6 | |
| Accounts receivable | −23 | 2 | −471,000 | −33 | −30 | |
| Prepaid expenses and other current assets | 8 | 2 | −7 | −6 | −4 | |
| Change in operating leases | 3 | 3 | −152,000 | −7,000 | −406,000 | |
| Accounts payable and accrued liabilities | 8 | 436,000 | −5 | 2 | 8 | |
| Accrued payroll and employee benefits | 807,000 | 495,000 | 4 | 6 | 20 | |
| Deferred revenues | 2 | −5 | 3 | −928,000 | 8 | |
| Net cash provided by operating activities | 132 | 145 | 127 | 94 | 125 | |
| Capital expenditures | −9 | −7 | −16 | −12 | −7 | |
| Net cash used in investing activities | −9 | −7 | −16 | −12 | 38 | |
| Payroll taxes for restricted stock units | −4 | −7 | −10 | −13 | −16 | |
| Repurchase of common stock | −97 | −6 | −24 | −156 | −7 | |
| Exercise of stock-based payment awards | 2 | 6 | 2 | 2 | 3 | |
| Dividends and dividend equivalent rights | −62 | −58 | −54 | −49 | −43 | |
| Net cash used in financing activities | −160 | −65 | −86 | −216 | −63 | |
| Effect of foreign currency exchange rates on cash and cash equivalents | 1 | −739,000 | 705,000 | −2 | 169,000 | |
| Net change in cash and cash equivalents | −37 | 72 | 26 | −136 | 100 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is EXPONENT INC's CIK number?
EXPONENT INC's SEC CIK number is 0000851520 (851520). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find EXPONENT INC's SEC filings?
All of EXPONENT INC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did EXPONENT INC last report earnings?
EXPONENT INC (EXPO) most recently filed an earnings 8-K with the SEC on Apr 30, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001171843-26-002896). This is EXPONENT INC's most recent earnings filing of record — not a forecast of its next earnings date.
What is EXPONENT INC's most recent earnings 8-K?
EXPONENT INC's latest earnings 8-K (Item 2.02) was filed Apr 30, 2026 under accession 0001171843-26-002896. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View EXPONENT INC's latest earnings 8-K →
Look up any company's CIK number →